(Q33507252)

27 July 2017

0 references

Two patients with leprosy and the sudden appearance of inflammation in the skin and new sensory loss (English)

1 reference

27 July 2017

0 references

Carlos Franco-Paredes

1

1 reference

27 July 2017

Jesse T Jacob

2

1 reference

27 July 2017

Barbara Stryjewska

3

1 reference

27 July 2017

Leo Yoder

4

1 reference

27 July 2017

language of work or name

English

0 references

publication date

29 September 2009

1 reference

PLoS Neglected Tropical Diseases

27 July 2017

published in

1 reference

27 July 2017

volume

3

1 reference

27 July 2017

issue

9

1 reference

27 July 2017

page(s)

e425

1 reference

Creative Commons Attribution 4.0 International

27 July 2017

copyright license

start time

29 September 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

The biology of nerve injury in leprosy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742893

Leprosy occurring as immune reconstitution syndrome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742893

Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742893

Early diagnosis of neuropathy in leprosy--comparing diagnostic tests in a large prospective study (the INFIR cohort study)

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742893

The histological diagnosis of leprosy type 1 reactions: identification of key variables and an analysis of the process of histological diagnosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742893

Towards understanding the pathology of erythema nodosum leprosum

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742893

The role of thalidomide in the management of erythema nodosum leprosum.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742893

Methotrexate treatment for type 1 (reversal) leprosy reactions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742893

The clinical and immunological features of leprosy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742893

Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742893

The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742893

Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PNTD.0000425

Global strategy for further reducing the leprosy burden and sustaining leprosy control activities 2006-2010. Operational guidelines.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742893

Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742893

Cyclosporine A treatment of leprosy patients with chronic neuritis is associated with pain control and reduction in antibodies against nerve growth factor.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2742893

The final push strategy to eliminate leprosy as a public health problem: questions and answers

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19787031

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The role of mycophenolate mofetil in the treatment of leprosy reactions

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19787031

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Development of leprosy and type 1 leprosy reactions after treatment with infliximab: a report of 2 cases

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19787031

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PNTD.0000425

1 reference

27 July 2017

1 reference

27 July 2017

1 reference